SUMMARY The linoleic acid intake of patients with multiple sclerosis is not significantly different from that of healthy control subjects. This is true both in absolute terms and when linoleic acid intake is expressed as a percentage of total fat intake. In the other categories of illness, included as control groups, linoleic acid intake was significantly decreased only in patients with acute non-neurological illness and in this case only when considered in absolute terms. In all groups studied the daily linoleic acid intake was in excess of 1.7% of the total calorie intake and in the case of multiple sclerosis was 2.7% of the total calories ingested. Since other workers have shown that linoleic acid absorption is not altered in multiple sclerosis and we have shown that the diet is not deficient, it seems that the decrease in linoleic acid content is due to some process occurring after the absorption of this essential fatty acid.
The prevalence of multiple sclerosis varies in different parts of the world with high risk zones occurring in the northern hemisphere, between latitudes 470 and 60°in Europe, and north of latitude 400 in North America (McAlpine, Lumsden, and Acheson, 1965) . While it is possible that this variation with latitude reflects the effects of climate and other environmental factors, an interesting observation was made-the difference in dietary habits with special reference to fat intake. Swank (1950 Swank ( , 1956 ) stated that the fat intake in high risk zones was above 100 g daily and below 50 g daily in low risk zones. Observations in Norway, Denmark, and Holland showed a decrease in the number of patients with multiple sclerosis admitted to hospital during the war years, when the amount of fat available was restricted (Swank, 1950 ). An increase in the dietary fat available in Norway and Denmark immediately after the war was associated with an increase in the number of multiple sclerosis patients admitted to hospital. Swank, Lerstad, Str0m, and Backer (1952) (Demole, 1943) . European Jews living in Israel eat more fat and have a greater incidence of multiple sclerosis than Yemenite Jews (Brunner and Lobl 1958; Alter, Halpern, Kurland, Bornstein, Leibowitz, and Silberstein 1962) . A survey in the Orkneys, Shetland, and Faroe Islands showed a greater prevalence of multiple sclerosis in the Orkney and Shetland Islands (Allison, 1963 (Baker, Thompson, and Zilkha, 1964, Gul, Smith, Thompson, Wright, and Zilkha, 1970) . The mechanism involved in the reduction of linoleic acid levels is not understood. The absorption of linoleic acid in patients with multiple sclerosis does not differ from nor-mal subjects (Belin, Pettet, Smith, Thompson, and Zilkha 1971) . It has been suggested that altered levels of linoleic acid could be related to either an increase in the intake of saturated fats or reduction in the intake of unsaturated fats in the diet (Thompson, 1966) . Dietary studies in multiple sclerosis relating linoleic acid intake with altered levels of linoleic acid in the serum have not been reported previously. In order to clarify this point we set up a quantitative dietary survey in a group of multiple sclerosis patients. Simultaneously with this dietary study the linoleic acid and fatty acid pattern of plasma lipids was investigated and a preliminary report has been published (Love, Cashell, Reynolds, and Callaghan, 1972) .
METHODS
We assessed 102 subjects in the dietary study. These included patients with multiple sclerosis of varying activity and three control groups comprising patients with neurological diseases other than multiple sclerosis, patients with acute non-neurological illnesses, and healthy subjects.
MULTIPLE SCLEROSIS PATIENTS Group A This consisted of 11 patients (five males and six females), with a mean age of 35 years. These patients were seen during acute exacerbations of the disease, but their incapacity before the acute exacerbation was minimal and did not interfere with their normal daily activities.
Group B This group consisted of 16 cases (seven males and nine females), with a mean age of 38 years. They showed progressive deterioration due to disease to the extent that it interfered with normal daily activities, but they were not confined to bed or to a wheelchair. The intake of saturated fats was at a higher level than unsaturated fats in all three groups, the greatest difference was in healthy subjects. wheelchair. Although patients with acute exacerbations were confined to bed when the study was carried out, the higher intake was probably related to the fact that their activities were not restricted to a great extent before admission to hospital; the lower intake in the other two groups was possibly related to prolonged periods of progressive inactivity. Table 5 shows the daily intake of linoleic acid in the various groups studied. In addition, linoleic acid intake is expressed as a percentage of both total and unsaturated fats. When compared with healthy controls the only group with a statistically significant reduction in linoleic acid intake were those with acute non-neurological illness. The intake of linoleic acid as a percentage of total fat and of unsaturated fatty acids was not significantly different in healthy controls from that of the ill patients group. Table 6 shows the intake of linoleic acid and the linoleic acid as a percentage of total fat and unsaturated fatty acids in multiple sclerosis during various phases of activity of the disease. No significant difference was found in the intake Table 7 shows the intake of total calories, protein, and carbohydrate of the healthy subjects and the ill patients. The intake of calories, protein, and carbohydrate was significantly reduced in all of the ill groups when compared with healthy controls; the lowest intake occurring in acute non-neurological illness. There was no significant difference in multiple sclerosis when compared with acute non-neurological illness or with neurological controls, or when neurological controls were compared with acute nonneurological illness. Table 8 shows the intake of calories, protein, and carbohydrate in multiple sclerosis during various phases of activity of the disease. The highest intake was found in patients with exacerbations of the disease and the lowest intake in those permanently confined to bed or to a wheelchair.
DISCUSSION
As shown in Table 5 , the intake of linoleic acid in multiple sclerosis is not significantly different from that of healthy controls or the other groups studied. Furthermore, when linoleic acid (Love et al., 1972) , which suggests that the dietary intake may play some part in the reduced serum linoleic acid in this group. However, the average daily intake in acute non-neurological illness is 4-7 g of linoleate which is 1.7% of total calories. This is well above the minimum linoleate requirement to maintain normal levels of dienoic, trienoic, and tetraenoic acids in serum lipids (Wiese, 1971 definite association between the pathogenesis of multiple sclerosis and dietary fat could be concluded from this study. The reduction in the intake of fat which was noted with progressive disability did not appear to halt the progress of the disease, although the intake was higher than the amount used by Swank (1953 Swank ( , 1955 Swank ( , 1956 Swank and Bourdillon, 1960; Swank, 1970) for the treatment of this disease.
The calorie intake of the control group was at a very high level and corresponded with the calorie requirements recommended for people involved in hard work in very cold climates (Davidson and Passmore, 1966) . It undoubtedly represents an intake of food in excess of requirements for the groups studied. The Food and Agricultural Organisation/World Health Organisation mission (1965) showed that, among the European countries studied, Ireland had the highest average calorie supplies per head of population with an average of 3,400 calories available, compared with an estimated requirement of 2,620 calories. The intake of calories, protein, carbohydrate, and fat was much higher than the areas studied in Norway by Swank et al. (1952) . No data are available on the prevalence of multiple sclerosis in the Republic of Ireland to compare with the dietary habits, although data available from Northern Ireland (Allison and Millar, 1954) 
